OphthaliX (OPH.RC)

Clinical-stage biotech developing treatments for ophthalmic disorders.

Other -

IPO Performance
Latest Trade ()
First Day Return
Return from IPO
 
OphthaliX IPO News more
  • .
IPO Data
IPO File Date 07/02/2013
Offer Price
Price Range n/a
Offer Shares (mm) n/a
Deal Size ($mm) $10
 
IPO Data
IPO Date
Offer Price
Price Range n/a
Offer Shares (mm) n/a
Deal Size ($mm) $$10
 
Underwriters
more
Business Overview
Clinical-stage biotech developing treatments for ophthalmic disorders.
Clinical-stage biotech developing treatments for ophthalmic disorders.
more
Company Data
Headquarters Petach Tikva, , Israel
Founded 1999
Employees 1
Website www.ophthalix.com
 

Performance vs. IPO Index (IPOUSA)